Featured Research

from universities, journals, and other organizations

Gene Expression Signature Associated With Survival In Advanced Ovarian Cancer

Date:
February 3, 2009
Source:
Public Library of Science
Summary:
A new study identifies molecular pathways associated with outcomes in ovarian cancer. Currently, outcomes following diagnosis of ovarian cancer are very poor, with up to 65-70 percent of women dying within five years of diagnosis.

A new study published this week in the open-access journal PLoS Medicine identifies molecular pathways associated with outcomes in ovarian cancer. Currently, outcomes following diagnosis of ovarian cancer are very poor, with up to 65-70% of women dying within five years of diagnosis.

Related Articles


Anne Crijns and her colleagues from the University of Groningen in the Netherlands aimed to find out whether the expression levels of particular genes were associated with overall survival in ovarian cancer. The researchers initially studied a series of tissue samples, obtained during surgery to remove cancerous tissue from 157 consecutive patients seen at the University Medical Center Groningen.

Analysis of the samples identified 86 genes which correlated with overall survival in the women. The researchers were then able to confirm, for 57 of the 86 genes, that these were also correlated with survival in a second, entirely separate dataset. Specific genes, and pathways, were identified which provide specific targets around which researchers might be able to design potential therapies in future.

For example, Crijns and colleagues find high expression of a gene encoding a FK506 binding protein, FKBP7, is associated with poor prognosis. This protein can be targeted with existing drugs, the mTOR inhibitors. Another implication of the work discussed by the researchers is the use of this expression signature to identify women who are at greater risk of relapse, and thus potentially personalize treatment. However, as the authors acknowledge, such implications are still some way off. It would be important to carry out prospective studies in order to show that the signature performs effectively in a clinical setting.

The new study is discussed in an expert commentary by Simon Gayther and Kate Lawrenson of University College London, who were not involved in the study.


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal References:

  1. Crijns APG, Fehrmann RSN, de Jong S, Gerbens F, Meersma GJ, et al. Survival-Related Profile, Pathways, and Transcription Factors in Ovarian Cancer. PLoS Medicine, 2009; 6 (2): e24 DOI: 10.1371/journal.pmed.1000024
  2. Lawrenson K, Gayther SA. Ovarian Cancer: A Clinical Challenge That Needs Some Basic Answers. PLoS Medicine, 2009; 6 (2): e25 DOI: 10.1371/journal.pmed.1000025

Cite This Page:

Public Library of Science. "Gene Expression Signature Associated With Survival In Advanced Ovarian Cancer." ScienceDaily. ScienceDaily, 3 February 2009. <www.sciencedaily.com/releases/2009/02/090202213317.htm>.
Public Library of Science. (2009, February 3). Gene Expression Signature Associated With Survival In Advanced Ovarian Cancer. ScienceDaily. Retrieved March 31, 2015 from www.sciencedaily.com/releases/2009/02/090202213317.htm
Public Library of Science. "Gene Expression Signature Associated With Survival In Advanced Ovarian Cancer." ScienceDaily. www.sciencedaily.com/releases/2009/02/090202213317.htm (accessed March 31, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, March 31, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Soda, Salt and Sugar: The Next Generation of Taxes

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Dinι Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline. Video provided by Washington Post
Powered by NewsLook.com
UnitedHealth Buys Catamaran

UnitedHealth Buys Catamaran

Reuters - Business Video Online (Mar. 30, 2015) — The $12.8 billion merger will combine the U.S.&apos; third and fourth largest pharmacy benefit managers. Analysts say smaller PBMs could also merge. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins